Barclays’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-35,000
| Closed | -$786K | – | 5339 |
|
|
2024
Q2 | $786K | Hold |
35,000
| – | – | ﹤0.01% | 2748 |
|
|
2024
Q1 | $831K | Buy |
+35,000
| New | +$778K | ﹤0.01% | 3268 |
|
|
2022
Q1 | – | Sell |
-900
| Closed | -$16K | – | 5149 |
|
|
2021
Q4 | $16K | Hold |
900
| – | – | ﹤0.01% | 3964 |
|
|
2021
Q3 | $19K | Sell |
900
-20,000
| -96% | -$371K | ﹤0.01% | 4406 |
|
|
2021
Q2 | $381K | Buy |
20,900
+20,000
| +2,222% | +$466K | ﹤0.01% | 3230 |
|
|
2021
Q1 | $20K | Sell |
900
-2,600
| -74% | -$58.7K | ﹤0.01% | 4370 |
|
|
2020
Q4 | $70K | Hold |
3,500
| – | – | ﹤0.01% | 4274 |
|
|
2020
Q3 | $86K | Sell |
3,500
-4,200
| -55% | -$98K | ﹤0.01% | 4327 |
|
|
2020
Q2 | $183K | Sell |
7,700
-22,900
| -75% | -$531K | ﹤0.01% | 4127 |
|
|
2020
Q1 | $527K | Sell |
30,600
-23,800
| -44% | -$435K | ﹤0.01% | 3537 |
|
|
2019
Q4 | $959K | Sell |
54,400
-42,400
| -44% | -$719K | ﹤0.01% | 3710 |
|
|
2019
Q3 | $1.71M | Sell |
96,800
-49,600
| -34% | -$1M | ﹤0.01% | 3061 |
|
|
2019
Q2 | $3.13M | Buy |
146,400
+93,600
| +177% | +$1.96M | ﹤0.01% | 2386 |
|
|
2019
Q1 | $1.26M | Sell |
52,800
-161,100
| -75% | -$3.67M | ﹤0.01% | 3146 |
|
|
2018
Q4 | $4.21M | Sell |
213,900
-10,700
| -5% | -$191K | ﹤0.01% | 1710 |
|
|
2018
Q3 | $3.98M | Sell |
224,600
-73,200
| -25% | -$1.43M | ﹤0.01% | 2052 |
|
|
2018
Q2 | $6.41M | Buy |
297,800
+72,300
| +32% | +$1.5M | 0.01% | 1537 |
|
|
2018
Q1 | $5M | Buy |
225,500
+127,000
| +129% | +$3.51M | ﹤0.01% | 1638 |
|
|
2017
Q4 | $2.99M | Sell |
98,500
-22,500
| -19% | -$599K | ﹤0.01% | 2067 |
|
|
2017
Q3 | $2.93M | Sell |
121,000
-32,600
| -21% | -$868K | ﹤0.01% | 1976 |
|
|
2017
Q2 | $3.78M | Buy |
153,600
+80,700
| +111% | +$1.71M | ﹤0.01% | 1676 |
|
|
2017
Q1 | $1.58M | Sell |
72,900
-18,800
| -21% | -$382K | ﹤0.01% | 2310 |
|
|
2016
Q4 | $1.37M | Sell |
91,700
-79,200
| -46% | -$1.14M | ﹤0.01% | 2448 |
|
|
2016
Q3 | $2.19M | Buy |
170,900
+69,800
| +69% | +$755K | ﹤0.01% | 1932 |
|
|
2016
Q2 | $790K | Sell |
101,100
-11,100
| -10% | -$64K | ﹤0.01% | 2821 |
|
|
2016
Q1 | $449K | Sell |
112,200
-25,200
| -18% | -$107K | ﹤0.01% | 3246 |
|
|
2015
Q4 | $687K | Sell |
137,400
-33,300
| -20% | -$186K | ﹤0.01% | 2940 |
|
|
2015
Q3 | $854K | Buy |
170,700
+128,900
| +308% | +$701K | ﹤0.01% | 2887 |
|
|
2015
Q2 | $125K | Sell |
41,800
-238,500
| -85% | -$775K | ﹤0.01% | 4504 |
|
|
2015
Q1 | $561K | Buy |
280,300
+18,200
| +7% | +$42.2K | ﹤0.01% | 3516 |
|
|
2014
Q4 | $262K | Buy |
262,100
+18,900
| +8% | +$29.5K | ﹤0.01% | 4409 |
|
|
2014
Q3 | $243K | Buy |
243,200
+15,900
| +7% | +$51K | ﹤0.01% | 4561 |
|
|
2014
Q2 | $682K | Sell |
227,300
-92,600
| -29% | -$320K | ﹤0.01% | 3689 |
|
|
2014
Q1 | $960K | Buy |
319,900
+294,600
| +1,164% | +$2.01M | ﹤0.01% | 3277 |
|
|
2013
Q4 | $152K | Sell |
25,300
-22,000
| -47% | -$121K | ﹤0.01% | 5270 |
|
|
2013
Q3 | $237K | Sell |
47,300
-9,900
| -17% | -$51.2K | ﹤0.01% | 4877 |
|
|
2013
Q2 | $260K | Buy |
+57,200
| New | +$271K | ﹤0.01% | 4927 |
|
Other funds holding EXEL
FCM
VPM
VCM
Barclays's EXEL Position: Q1 2026 in Review
Barclays reduced its Exelixis (EXEL) stake by 37% in Q1 2026, selling an estimated $12.9M and leaving 504,289 shares worth $21.6M. The position accounts for 0.01% of the portfolio, ranked #1063.
Barclays first reported a position in EXEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.3M in Q4 2025. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Barclays held 504,289 shares of Exelixis worth $21.6M as of Q1 2026.
- Barclays sold 300,762 Exelixis shares in Q1 2026, an estimated $12.9M.
- Exelixis made up 0.01% of Barclays's portfolio in Q1 2026, its #1063 holding.
- Barclays first reported a position in Exelixis in Q2 2013 and has held it in 52 quarters since.
- Barclays's Exelixis position peaked at $35.3M in Q4 2025.
- 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.